Leef Brands (LEEEF) Work In Process (2024 - 2026)

Leef Brands (LEEEF) reported Work In Process of $1.4 million for Q1 2026, up 26.35% sequentially from $1.1 million in Q4 2025.

Leef Brands (LEEEF) Work In Process (2024 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 3 years of Work In Process data on file, last reported at $1.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Work In Process changed N/A year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (changed N/A YoY), and the FY2025 full-year result was $1.1 million, down 10.36% from the prior year.
  • Work In Process rose to $1.4 million in Q1 2026, from $1.1 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $1.4 million in Q1 2026 to a low of $1.1 million in Q4 2025.
  • A 3-year average of $1.3 million and a median of $1.2 million in 2024 frame the typical range for Work In Process.
  • Peak annual rise in Work In Process reached 10.36% in 2025, while the deepest fall reached 10.36% in 2025.
  • Tracing LEEEF's Work In Process over 3 years: stood at $1.2 million in 2024, then decreased by 10.36% to $1.1 million in 2025, then climbed by 26.35% to $1.4 million in 2026.
  • Business Quant data shows LEEEF's Work In Process at $1.4 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.41 Mn
Dec 31, 2025 1.11 Mn
Dec 31, 2024 1.24 Mn